We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Zelboraf

News List

Roche gets US FDA approval for Tecentriq combo to treat advanced melanoma expresspharma
August 03, 2020
The approval is based on results from the Phase III IMspire150 study, in which the addition of Tecentriq to Cotellic and Zelboraf helped people live longer without disease worsening or death.
FDA approves first treatment for certain patients with Erdheim-Chester Disease, a rare blood cancer worldpharmanews
November 08, 2017
The U.S. Food and Drug Administration has expanded the approval of Zelboraf (vemurafenib) to include the treatment of certain adult patients with Erdheim-Chester Disease (ECD), a rare cancer of the blood
FDA approves Zelboraf for certain patients with Erdheim-Chester disease europeanpharmaceuticalreview
November 08, 2017
The FDA has expanded the approval of Zelboraf to include the treatment of certain adult patients with Erdheim-Chester Disease, a rare cancer of the blood…